Moduladores enzimáticos
Moduladores de enzimas são compostos que podem aumentar ou inibir a atividade de enzimas, regulando assim a taxa de reações bioquímicas. Esses moduladores desempenham um papel crucial no controle de vias metabólicas, sinalização celular e vários processos fisiológicos. Os moduladores de enzimas são amplamente utilizados em pesquisa e desenvolvimento de medicamentos para estudar as funções enzimáticas e desenvolver agentes terapêuticos. Na CymitQuimica, oferecemos uma ampla gama de moduladores de enzimas de alta qualidade para apoiar sua pesquisa em regulação enzimática e descoberta de medicamentos.
Subcategorias de "Moduladores enzimáticos"
Foram encontrados 693 produtos de "Moduladores enzimáticos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Licofelone
CAS:<p>Dual COX/5-LO inhibitor; anti-inflammatory; analgesic</p>Fórmula:C23H22ClNO2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:379.88 g/molRasagiline mesylate
CAS:Produto Controlado<p>Monoamine oxidase-B inhibitor; anti-parkinsonian; neuroprotective</p>Fórmula:C12H13N•CH4O3SPureza:Min. 95%Cor e Forma:PowderPeso molecular:267.35 g/molAZD 1152
CAS:<p>AZD 1152 is an Aurora kinase inhibitor, which is a type of small-molecule therapeutic agent. It is derived from the pharmaceutical research conducted by AstraZeneca. Its primary mode of action involves the selective inhibition of Aurora B kinase, an enzyme crucial for the regulation of mitosis. By interfering with this enzyme, AZD 1152 disrupts the normal progression of cell division, leading to the inhibition of proliferation and induction of apoptosis in rapidly dividing cells.</p>Fórmula:C26H31FN7O6PPureza:Min. 97 Area-%Cor e Forma:Slightly Yellow PowderPeso molecular:587.54 g/molCerivastatin sodium
CAS:<p>An inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase that reduces total cholesterol and low-density lipoprotein (LDL). Cerivastatin is cardioprotective and anti-atherosclerotic. Cerivastatin inhibits the expression of the atherosclerotic genes monocyte chemoattractant protein-1 (MCP-1) and C-C chemokine receptor type 2 (CCR2), whilst inducing the expression of Kruppel-like factor 2 (KLF2).</p>Fórmula:C26H33FNNaO5Pureza:Min. 98 Area-%Cor e Forma:PowderPeso molecular:481.53 g/molSU 11274
CAS:<p>MET tyrosine kinase inhibitor; anti-proliferative; pro-apoptotic</p>Fórmula:C28H30ClN5O4SPureza:Min. 95%Cor e Forma:Yellow To Orange SolidPeso molecular:568.09 g/molOmeprazole - Bio-X ™
CAS:<p>Omeprazole is a proton pump inhibitor (PPI) that inhibits the production of gastric acid in the stomach. This is due to Omeprazole binding through a stable disulphide bond to the H+/K+ ATPase enzyme found on parietal cells, and preventing hydrogen ion transport. Consequently, gastric acid secretion is supressed. As a PPI, Omerprazole can be used to treat disorders where gastric acid is over-secreted. Examples of these disorders are gastroesophageal reflux disease (GERD) and peptic ulcer disease.</p>Fórmula:C17H19N3O3SPureza:Min. 95%Cor e Forma:PowderPeso molecular:345.42 g/molAceclofenac - Bio-X ™
CAS:<p>Acecelofenac is a non-steroidal anti-inflammatory drug that is used in the treatment of osteoarthritis, arthritis, and ankylosing spondylitis. This drug is also a cyclooxygenase inhibitor and works by inhibiting this enzyme so that pain and inflammation is reduced.</p>Fórmula:C16H13Cl2NO4Pureza:Min. 95%Cor e Forma:PowderPeso molecular:354.18 g/molRivastigmine tartrate - Bio-X ™
CAS:Produto Controlado<p>Rivastigmine is a cholinergic agent that is used in the treatment of dementia in Parkinson’s and Alzheimer’s disease. This drug is a carbamate derivative that binds to and inactivates cholinesterase such as acetylcholinesterase and butyrylcholinesterase. This leads to an increase concentration of acetylcholine at cholinergic synapse.</p>Fórmula:C14H22N2O2•C4H6O6Pureza:Min. 95%Cor e Forma:PowderPeso molecular:400.42 g/molTideglusib
CAS:<p>An irreversible GSK-3β inhibitor that reduces phosphorylation of tau proteins, protects from neuronal loss and has cognitive and behavioural benefits in murine models. Studied for its potential as a therapeutic agent in Alzheimer’s disease and other neurodegenerative diseases. Tideglusib was also shown to inhibit the main protease Mpro from the SARS-CoV-2 virus with IC50 of 1.55 μM.</p>Fórmula:C19H14N2O2SPureza:Min. 95%Cor e Forma:White To Off-White SolidPeso molecular:334.39 g/molChymostatin
CAS:<p>Inhibitor of chymotrypsin</p>Fórmula:C31H41N7O6Cor e Forma:White To Yellowish SolidPeso molecular:607.7 g/molBAY 607550
CAS:<p>A selective and potent inhibitor of phosphodiesterase 2 (PDE2). Raises cAMP and cGMP levels in neurons, improves social recognition and object memory in murine animals. Reverses anxiolytic effects induced by oxidative stress in mice by blocking cGMP-PKG signaling.</p>Fórmula:C27H32N4O4Pureza:Min. 95%Cor e Forma:PowderPeso molecular:476.24236Zotarolimus
CAS:<p>Inhibitor of immunophilin FKBP12 and mTOR signalling with immunosuppressant activity. Zotarolimus inhibits proliferation of endothelial cells and smooth muscle cells and is employed in vascular interventional therapies.</p>Fórmula:C52H79N5O12Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:966.21 g/molRebamipide - Bio-X ™
CAS:<p>Rebamipide is a gastroprotective agent that is used to treat various gastrointestinal disorders such as gastric ulcers and GERD. This drug’s mechanism of action is not fully understood however, it is thought to exert its effects by promoting the secretion of protective mucus in the stomach and intestine, which helps to create a barrier against stomach acid and other irritants. Additionally, it has antioxidant and anti-inflammatory properties that can help reduce tissue damage.</p>Fórmula:C19H15ClN2O4Pureza:Min. 95%Cor e Forma:PowderPeso molecular:370.79 g/molAG 120
CAS:<p>Inhibits isocitrate dehydrogenase 1 (IDH-1) harbouring a gain of function mutation at R132, which causes impaired cellular differentiation via epigenetic modulation. By inhibiting mutant IDH1, synthesis of oncometabolite 2-hydroxyglutarate is reduced. This compound therefore has therapeutic potential in solid and haematological malignancies, such as acute myeloid leukemia (AML).</p>Fórmula:C28H22ClF3N6O3Pureza:Min. 95%Cor e Forma:White To Off-White SolidPeso molecular:582.96 g/molGilteritinib
CAS:<p>Inhibitor of FLT3 and AXL tyrosine kinases</p>Fórmula:C29H44N8O3Pureza:Min. 95%Cor e Forma:PowderPeso molecular:552.71 g/molXMU MP 2
CAS:<p>BRK tyrosine kinase (PTK6) inhibitor; anti-proliferative in breast cancer cells</p>Fórmula:C32H33F3N8O2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:618.65 g/molCZC 25146
CAS:<p>Inhibitor of leucine-rich repeat kinase LRRK2Â</p>Fórmula:C22H25FN6O4SPureza:Min. 98 Area-%Cor e Forma:PowderPeso molecular:488.54 g/molLovastatin - Bio-X ™
CAS:<p>Lovastatin is an HMG-CoA reductase inhibitor that is used to lower LDL cholesterol levels and to aid in the management of cardiovascular diseases. Animal studies have demonstrated that this drug has vasculoprotective properties.</p>Fórmula:C24H36O5Pureza:Min. 95%Cor e Forma:PowderPeso molecular:404.54 g/molMRK 560
CAS:<p>γ-secretase inhibitor; reduces amyloid-β in brainÂ</p>Fórmula:C19H17ClF5NO4S2Pureza:Min. 95%Peso molecular:517.92 g/molApremilast - Bio-X ™
CAS:<p>Apremilast is the commercial name of a phosphodiesterase-4 (PDE4) inhibitor developed to treat chronic inflammatory disorders. Similarly to thalidomide, the apremilast molecule carries a phthalimide ring, but it lacks however the glutarimide ring needed to bind to cereblon, specifically targeted by thalidomide. As a drug, apremilast is indicated for the treatment of psoriasis and psoriatic arthritis.</p>Fórmula:C22H24N2O7SPureza:Min. 99 Area-%Cor e Forma:White/Off-White SolidPeso molecular:460.5 g/mol
